PELICAN
Laufzeit: 01.01.2006 - 31.12.2008
Laufzeit: 01.01.2006 - 31.12.2008
A multinational, subsiadary sponsored, randomized, open-label study comparing treatment with either pegylated liposomal Doxorubicin or Capecitabine as first line chemotherapy for metastatic breast cancer